BackZynerba Pharmaceuticals Overview

Zynerba Pharmaceuticals Research & Development

Research & Development expenses for ZYNE.

Quarterly R&D Expenses

$7.17M
↑ 31.59% YoY

As of Jun 30, 2023

Annual R&D Expenses (TTM)

$24.75M
↑ 12.73% YoY

Trailing 12 months ending Jun 30, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin